Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Medications › prednisolone

prednisolone

6 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials of prednisolone

43 trials tracked of prednisolone: 21 in phase 3 or 4 and 10 with published results. The most-cited published study has 265 citations.

43Trials tracked
21Phase 3 & 4
0Recruiting
10With published results
Phase distribution
Phase 4 9 Phase 3 12 Phase 2 18 Phase 1 3 Other / NA 1
  1. Phase 3 Treatment of Preschool Children With Upper Respiratory Tract Illnesses Using Azythromycin and Lower Respiratory Tract Symptoms Using Oral Corticosteroids. Completed · 265 cited
  2. Phase 3 05-001: Treatment of Acute Lymphoblastic Leukemia in Children Completed · 238 cited
  3. Phase 4 The Glucocorticoid Low-dose Outcome in RheumatoId Arthritis Study Completed · 159 cited
  4. Phase 3 Study of Pembrolizumab (MK-3475) Plus Olaparib Versus Abiraterone Acetate or Enzalutamide in Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-7339-010/KEYLYNK-010) Completed · 131 cited
  5. Phase 4 The Safety and Efficiency of Propranolol as an Initial Treatment for Pediatric Hemangioma Completed · 61 cited
  6. Phase 3 A Study to Assess the Benefit of Treatment Beyond Progression With Enzalutamide in Men Who Are Starting Treatment With Docetaxel After Worsening of Their Prostate Cancer When Taking Enzalutamide Alone Completed · 39 cited
Show 37 more trials
  1. Phase 3 Study to Demonstrate Non-Inferior Efficacy and Safety of CinnoRA® Versus Humira® for Treatment of Active RA Completed · 33 cited
  2. Phase 4 Tacrolimus Versus Prednisolone for the Treatment of Minimal Change Disease Completed · 19 cited
  3. Phase 3 Velcade (Bortezomib) Consolidation After Transplant Completed · 17 cited
  4. Phase 4 Intracanalicular Dexamethasone Insert for Post-Corneal Cross-Linking Inflammation and Pain- The LINK Study Completed · 4 cited
  5. Phase 4 Prednisolone Pharmacokinetics in Severe Asthma Completed
  6. Phase 4 Early Administration of Steroids in the Ambulance Setting Completed
  7. Phase 4 A Clinical Trial to Study the Effects of Two Drugs, Lycopene and Prednisolone in Patients With Oral Lichen Planus Completed
  8. Phase 4 A Study of Sodium Carboxymethylcellulose for Post Cataract Surgery Dry Eye Symptoms Completed
  9. Phase 4 A Comparison of Three Different Formulations of Prednisolone Acetate 1% Completed
  10. Phase 3 Nepafenac Once Daily for Macular Edema - Study 2 Completed
  11. Phase 3 Nepafenac Once Daily for Macular Edema - Study 1 Completed
  12. Phase 3 Timed Release Tablet Prednisone in Polymyalgia Rheumatica Completed
  13. Phase 3 Study to Evaluate the Safety for the Treatment of Inflammation Associated With Cataract Surgery Completed
  14. Phase 3 To Study the Effectiveness and Safety of Niacin and a Topical Steroid Eye Drop to Treat Retinal Vein Occlusions Completed
  15. Phase 3 Long-term Access Program (LAP) of Mepolizumab for Subjects Who Participated in Study MEA115921 Completed
  16. Phase 2 Early Phase Study to Assess Efficacy and Safety of AZD9567 Versus Prednisolone in Patients With Rheumatoid Arthritis Completed
  17. Phase 2 E3-Hormone Refractory Prostrate Cancer Taxotere Combination Completed
  18. Phase 2 Study of Ipatasertib or Apitolisib With Abiraterone Acetate Versus Abiraterone Acetate in Participants With Castration-Resistant Prostate Cancer Previously Treated With Docetaxel Chemotherapy Completed
  19. Phase 2 A Safety and Efficacy Study of Mycophenolate Mofetil and Rilonacept in Patients With Alcoholic Hepatitis Completed
  20. Phase 2 Multicenter Study to Evaluate CRx-102 vs. Each of Its Components to Treat Active Rheumatoid Arthritis Completed
  21. Phase 2 Treatment of Patients With Diffuse Large B Cell Lymphoma Who Are Not Suitable for Anthracycline Containing Chemotherapy Completed
  22. Phase 2 Comparison of Two Steroid Regimens to Prevent Transplant Rejection After Corneal Transplant (DMEK) Completed
  23. Phase 2 Nivolumab With Standard of Care Chemotherapy for Peripheral T Cell Lymphomas Completed
  24. Phase 2 Study to Assess the Effect on Glucose Homeostasis of Two Dose Levels of AZD9567, Compared to Prednisolone, in Adults With Type 2 Diabetes Completed
  25. Phase 2 Historically Controlled Trial of Corticosteroids in Young Boys With Duchenne Muscular Dystrophy Completed
  26. Phase 2 A Phase II Trial Comparing Z-102 With Placebo In Patients With Moderate To Severe Rheumatoid Arthritis Completed
  27. Phase 2 A Study of Polatuzumab Vedotin in Combination With Rituximab or Obinutuzumab, Cyclophosphamide, Doxorubicin, and Prednisone in Participants With B-Cell Non-Hodgkin's Lymphoma Completed
  28. Phase 2 Study of Tazemetostat as Single Agent in Solid Tumors or B-cell Lymphomas and in Combination With Prednisolone in DLBCL Completed
  29. Phase 2 Bortezomib Plus CHOP Every 2 Weeks for Advanced Stage DLBCL Completed
  30. Phase 2 Azacitidine and Combination Chemotherapy in Treating Infants With Acute Lymphoblastic Leukemia and KMT2A Gene Rearrangement Completed
  31. Phase 2 Selonsertib in Combination With Prednisolone Versus Prednisolone Alone in Participants With Severe Alcoholic Hepatitis (AH) Completed
  32. Phase 2 A Study of Abiraterone Acetate (JNJ-212082) and Prednisolone in Patients With Advanced Prostate Cancer Completed
  33. Phase 2 A Placebo-controlled Phase 2 Trial to Investigate the Safety and Efficacy of Secukinumab in Giant Cell Arteritis Completed
  34. Phase 1 A Single Ascending Dose Study To Assess The Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of AZD9567. Completed
  35. Phase 1 Palbociclib in Combination With Chemotherapy in Treating Children With Relapsed Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma (LL) Completed
  36. Phase 1 A Study of JNJ-26866138 (Bortezomib) in Untreated Multiple Myeloma Patients Who Are Not Candidates for Hematopoietic Stem Cell Transplant (HSCT) Completed
  37. N/A Evaluation of TNF-α Blockade Effect in Patients With Severe Cutaneous Adverse Drug Reactions Completed

Showing the 43 most-cited and recently-updated of 43 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Short-term prednisolone bridging enables 95% discontinuation in new rheumatoid arthritis patients after 24 months
Rheumatology RCT
Short-term prednisolone bridging enables 95% discontinuation in new rheumatoid arthritis patients after 24 months Most patients stop steroid use after a short bridge to methotrexate treatment
This randomized controlled trial enrolled 230 patients with newly diagnosed rheumatoid arthritis naive to disease-modifying antirheumatic dr…
A trial of 230 patients with new rheumatoid arthritis found that most could stop using prednisolone after just seven weeks of short-term bri…
Jun 5, 2026
Network meta-analysis compares adjunctive therapies for proliferative vitreoretinopathy
Ophthalmology Meta-analysis
Network meta-analysis compares adjunctive therapies for proliferative vitreoretinopathy Oral retinoic acid shows promise for retinal detachment repair
Oral retinoic acid significantly improves retinal reattachment rates in PVR patients, with strong evidence for visual acuity and reduced com…
A study found oral retinoic acid may improve retinal reattachment rates after surgery for certain eye conditions, offering a potential new t…
Jun 1, 2026
Mycophenolate mofetil non-inferior to prednisone for first-episode nephrotic syndrome in children
Pediatrics RCT
Mycophenolate mofetil non-inferior to prednisone for first-episode nephrotic syndrome in children Mycophenolate Mofetil Offers Alternative to Steroids for Nephrotic Syndrome
This phase 3 non-inferiority trial randomized 272 children aged 1-10 years with first-episode steroid-sensitive nephrotic syndrome to mycoph…
A new trial shows mycophenolate mofetil works as well as prednisone for children with nephrotic syndrome, with fewer steroid side effects.
May 1, 2026
Obesity associated with reduced SLE relapse rates in Japanese registry cohort
Neurology Cohort
Obesity associated with reduced SLE relapse rates in Japanese registry cohort A Surprising Link Between Weight and Lupus Flares
This observational cohort study of 1134 patients with systemic lupus erythematosus in Japan found that obesity (BMI ≥25 kg/m2) was associate…
Being overweight or mildly obese might lower the risk of lupus relapses, challenging common beliefs about weight and autoimmune disease.
Frontiers Apr 19, 2026
Dazdotuftide inferior to prednisolone for uveitis inflammation but superior IOP safety in phase 3 trial
Drug Pipeline RCT
Dazdotuftide inferior to prednisolone for uveitis inflammation but superior IOP safety in phase 3 trial New Eye Drops Control Inflammation Without the Glaucoma Risk
In a randomized, double-masked, multicenter phase 3 trial of 136 adult and pediatric patients with active anterior noninfectious uveitis, to…
This new treatment offers a safer way to calm eye inflammation without raising the pressure that can lead to blindness.
Apr 17, 2026
Prednisolone plus standard treatment did not significantly reduce coronary-artery lesions in newly diagnosed Kawasaki disease patients
Cardiology RCT
Prednisolone plus standard treatment did not significantly reduce coronary-artery lesions in newly diagnosed Kawasaki disease patients Adding prednisolone to standard care did not prevent heart damage in Kawasaki disease patients
This multicenter, open-label, randomized, controlled trial evaluated 3208 participants with newly diagnosed Kawasaki disease in China.
Adding prednisolone to standard care did not prevent heart damage in Kawasaki disease patients, as lesion rates remained nearly the same.
Apr 16, 2026